Bruce Jenett's practice is focused on the representation of US and international business and finance clients in the life sciences industry. He is highly experienced in equity and debt financing, licensing and distribution, strategic alliances, joint ventures and mergers and acquisitions, as well as general counseling issues, representing both start-ups and large multinational corporations. Mr. Jenett has, for example, represented clients in one of the largest (in financial terms) ag-bio partnering deals in history, and one of the largest (also in financial terms) partnering deals done by an Irish venture capital-backed biotechnology company with a major pharmaceutical company. Mr. Jenett has represented such clients as Abingworth Management, Inc., Astellas Venture Capital LLC, Bayer Corporation and Bayer AG, CardioGenesis Corporation, Entelos, Inc., Exelixis, Inc., Hitachi Chemical Diagnostics, Intellikine, Novo Ventures (US), Inc., OptiMedica Corporation, Pelikan Technologies, Inc., Perlegen Sciences, TPG Ventures, VisionCare Ophthalmic Technologies, Inc. and several start-up incubators.

Mr. Jenett is a frequent speaker on corporate and finance issues to both business and lawyer audiences. He is a member of the Bioethics Committee of BIO (the Biotechnology Industry Organization), and of the Board of Directors of BayBio (the Northern California life sciences industry association), and is a member of, and is Chair of the Strategic Planning Committee of, San Francisco Mayor Gavin Newsom's Biotech Advisory Council.

Chambers USA: America's Leading Lawyers for Business, by the respected research publisher Chambers & Partners, consistently names Mr. Jenett as one of the leading life sciences lawyers in the United States. He is listed as a leading biotechnology industry lawyer in The Best Lawyers In America for 2007 and 2008, is on the Law & Politics Super Lawyers list for Northern California for corporate and securities law for 2007, 2008 and 2009, and is listed in The International Who's Who of Life Sciences Lawyers 2008, and in the San Francisco Business Times "2009 Best Lawyers in The Bay Area" and "Best Biotechnology Lawyers."

Admissions

• California
• New York